Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 26Colorectal Neoplasms 6Recurrence 5Liver Neoplasms 4Cholangiocarcinoma 3Secondary Malignant Neoplasm of Liver 1Reperfusion Injury 1Postoperative Complications 1Pancreatic Neoplasms 1Obesity, Morbid 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Metabolic Syndrome 1Klatskin Tumor 1Disseminated Pancreatic Cancer 1Disease Progression 1Conversion Disorder 1Colonic Neoplasms 1Abdominal Injuries 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Hepatectomy × Clear all
NCT03131778 2017-05-01

The Inflammatory Response to Stress and Angiogenesis in Liver Resection

University Hospital, Ghent

Phase NA Completed
40 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡